Adam Keeney PhD
Cambridge, Massachusetts, United States
1K followers
500+ connections
Cambridge, Massachusetts, United States
1K followers
500+ connections
Activity
-
I’m excited to share that we are hiring this highly visible and impactful leadership role on the alliance management team. It’s a unique opportunity…
I’m excited to share that we are hiring this highly visible and impactful leadership role on the alliance management team. It’s a unique opportunity…
Liked by Adam Keeney PhD
-
We’re proud to welcome HI-Bio: A Biogen Company employees to Biogen, working together to accelerate research and development to address high unmet…
We’re proud to welcome HI-Bio: A Biogen Company employees to Biogen, working together to accelerate research and development to address high unmet…
Liked by Adam Keeney PhD
-
Today, Biogen completed the acquisition of immune-mediated disease company HI-Bio. Learn more about the acquisition: https://ow.ly/uVKJ50StGbo
Today, Biogen completed the acquisition of immune-mediated disease company HI-Bio. Learn more about the acquisition: https://ow.ly/uVKJ50StGbo
Liked by Adam Keeney PhD
Experience & Education
-
Biogen
View Adam’s full experience
See their title, tenure and more.
or
More activity by Adam
-
Delighted to have Hi-Bio colleagues join Biogen. Welcome and we look forward to working with you to transform patient lives!
Delighted to have Hi-Bio colleagues join Biogen. Welcome and we look forward to working with you to transform patient lives!
Liked by Adam Keeney PhD
-
We are pleased to share that the acquisition of HI-Bio by Biogen has been completed. Combining our talented teams, complementary capabilities, and…
We are pleased to share that the acquisition of HI-Bio by Biogen has been completed. Combining our talented teams, complementary capabilities, and…
Liked by Adam Keeney PhD
-
Treatments for Alzheimer’s can mean more to patients and caregivers than just slowing down the disease. They can mean more time to do things on their…
Treatments for Alzheimer’s can mean more to patients and caregivers than just slowing down the disease. They can mean more time to do things on their…
Liked by Adam Keeney PhD
-
Congratulations to NodThera on continued progress on their NLRP3 franchise and initiating preparations for Phase IIs in obesity, cardiometabolic…
Congratulations to NodThera on continued progress on their NLRP3 franchise and initiating preparations for Phase IIs in obesity, cardiometabolic…
Liked by Adam Keeney PhD
-
I am excited to share that I have stepped up to be the CEO at Coulter Partners. My journey in executive search began 25 years ago, and I had the…
I am excited to share that I have stepped up to be the CEO at Coulter Partners. My journey in executive search began 25 years ago, and I had the…
Liked by Adam Keeney PhD
-
Today we reached another exciting clinical milestone in our journey to deliver a paradigm shift in the treatment of chronic inflammatory diseases…
Today we reached another exciting clinical milestone in our journey to deliver a paradigm shift in the treatment of chronic inflammatory diseases…
Liked by Adam Keeney PhD
-
We are honored to be recognized by the National Organization for Rare Disorders with the 2024 Industry Innovation Award for our work in Friedreich…
We are honored to be recognized by the National Organization for Rare Disorders with the 2024 Industry Innovation Award for our work in Friedreich…
Liked by Adam Keeney PhD
-
We were honored to join members of the amyotrophic lateral sclerosis (ALS) community at the Muscular Dystrophy Association’s Wings Over Wall Street…
We were honored to join members of the amyotrophic lateral sclerosis (ALS) community at the Muscular Dystrophy Association’s Wings Over Wall Street…
Liked by Adam Keeney PhD
-
We’re sharing our latest data in infants and toddlers with spinal muscular atrophy (SMA) at the Cure SMA Annual SMA Research and Clinical Care…
We’re sharing our latest data in infants and toddlers with spinal muscular atrophy (SMA) at the Cure SMA Annual SMA Research and Clinical Care…
Liked by Adam Keeney PhD
-
Over the weekend, members of our team attended the American Transplant Congress (ATC) to further discuss the recent positive felzartamab data in…
Over the weekend, members of our team attended the American Transplant Congress (ATC) to further discuss the recent positive felzartamab data in…
Liked by Adam Keeney PhD
-
We’re excited to welcome Frank Nestle, M.D., FMedSci, as Partner on the Therapeutics team and Chief Executive Officer of Deerfield Discovery and…
We’re excited to welcome Frank Nestle, M.D., FMedSci, as Partner on the Therapeutics team and Chief Executive Officer of Deerfield Discovery and…
Liked by Adam Keeney PhD
-
Yesterday, the European Commission approved our treatment for amyotrophic lateral sclerosis (ALS) in adults who have a specific gene…
Yesterday, the European Commission approved our treatment for amyotrophic lateral sclerosis (ALS) in adults who have a specific gene…
Liked by Adam Keeney PhD
-
We’re pleased to share that the European Commission has approved our treatment for amyotrophic lateral sclerosis (ALS) in adults who have a specific…
We’re pleased to share that the European Commission has approved our treatment for amyotrophic lateral sclerosis (ALS) in adults who have a specific…
Liked by Adam Keeney PhD
-
Very excited to expand our collaboration with the team at Nxera Pharma
Very excited to expand our collaboration with the team at Nxera Pharma
Liked by Adam Keeney PhD
People also viewed
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More